<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HF3BD00E161E640F9B30017880DBBDF7A" public-private="public">
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>112th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 6190</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20120725">July 25, 2012</action-date>
			<action-desc><sponsor name-id="B001248">Mr. Burgess</sponsor> (for
			 himself, <cosponsor name-id="R000573">Mr. Ross of Arkansas</cosponsor>,
			 <cosponsor name-id="B000213">Mr. Barton of Texas</cosponsor>,
			 <cosponsor name-id="P000373">Mr. Pitts</cosponsor>,
			 <cosponsor name-id="C001051">Mr. Carter</cosponsor>, and
			 <cosponsor name-id="M001142">Mr. Matheson</cosponsor>) introduced the following
			 bill; which was referred to the <committee-name committee-id="HIF00">Committee
			 on Energy and Commerce</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To direct the Administrator of the Environmental
		  Protection Agency to allow for the distribution, sale, and consumption in the
		  United States of remaining inventories of over-the-counter CFC epinephrine
		  inhalers.</official-title>
	</form>
	<legis-body id="HFB5D1A2A5F7A4A99AD3D25EF032A0D23" style="OLC">
		<section id="HDAE3BE189C414310A920F9058D85400E" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Asthma Inhalers Relief Act of
			 2012</short-title></quote>.</text>
		</section><section id="HE4AA039CF96B45EDAD09B76078F15451"><enum>2.</enum><header>Distribution,
			 sale, and consumption of remaining inventories of over-the-counter CFC
			 epinephrine inhalers</header>
			<subsection id="H54A857FD282948E8B1B9B1CE219B8ED2"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">The Administrator of
			 the Environmental Protection Agency—</text>
				<paragraph id="H62A6D422FFF14F8E90F6A2F5DDB4A6A9"><enum>(1)</enum><text display-inline="yes-display-inline">shall allow for the distribution, sale, and
			 consumption in the United States of remaining inventories of CFC epinephrine
			 inhalers manufactured pursuant to the exception for medical devices under
			 section 604(d)(2) of the Clean Air Act (42 U.S.C. 7671c(d)(2));</text>
				</paragraph><paragraph id="H5B7F7ADD2694465E828D279359537940"><enum>(2)</enum><text display-inline="yes-display-inline">shall not take any enforcement action or
			 otherwise seek to restrict the distribution, sale, or consumption of such
			 inhalers on the basis of any Federal law implementing the Montreal Protocol;
			 and</text>
				</paragraph><paragraph id="HF8914AE280C445B5B3DE5BCB2D814523"><enum>(3)</enum><text>shall, in response
			 to any request of any distributor or seller of such inhalers, including any
			 such request pending on the date of the enactment of this Act, issue a No
			 Action Assurance Letter to the requesting party stating that the Environmental
			 Protection Agency will not initiate an enforcement action relating to the
			 distribution or sale of any such inhaler occurring prior to August 1,
			 2013.</text>
				</paragraph></subsection><subsection id="HB19A16F06A0449E9AC918EC0087F764E"><enum>(b)</enum><header>Rule of
			 construction</header><text display-inline="yes-display-inline">Nothing in this
			 Act shall be construed to limit or otherwise affect the authority of the Food
			 and Drug Administration under the Federal Food, Drug, and Cosmetic Act (21
			 U.S.C. 301 et seq.) to ensure the safety and effectiveness of CFC epinephrine
			 inhalers to be distributed, sold, or consumed pursuant to this Act.</text>
			</subsection><subsection id="H22A66E744B0646058A42D92DB4E52C76"><enum>(c)</enum><header>Definitions</header><text>In
			 this Act:</text>
				<paragraph id="H97FD5A5218AB4BC09B0449E5C9563DD1"><enum>(1)</enum><text display-inline="yes-display-inline">The term <term>CFC epinephrine
			 inhaler</term> means any epinephrine inhaler containing
			 chlo­ro­fluo­ro­car­bons that was manufactured and classified as
			 over-the-counter before January 1, 2012.</text>
				</paragraph><paragraph id="HC2C9750597EB40F9ABB2A21E42935FB7"><enum>(2)</enum><text>The phrase
			 <term>Federal law implementing the Montreal Protocol</term>—</text>
					<subparagraph id="H790E519539074C3088302EC457CA8301"><enum>(A)</enum><text display-inline="yes-display-inline">means any provision of title VI of the
			 Clean Air Act (42 U.S.C. 7671 et seq.) or other Federal law implementing the
			 Montreal Protocol; and</text>
					</subparagraph><subparagraph id="HAE301B0765DC45C38ADF4879FB7EBB79"><enum>(B)</enum><text display-inline="yes-display-inline">includes the final rule published by the
			 Food and Drug Administration entitled <term>Use of Ozone-Depleting Substances;
			 Removal of Essential-Use Designation (Epinephrine)</term> published in the
			 Federal Register at 73 Federal Register 69532 (November 19, 2008).</text>
					</subparagraph></paragraph><paragraph id="H948628984A9449E6AB1016A6E159FED9"><enum>(3)</enum><text>The term
			 <term>Montreal Protocol</term> has the meaning given such term in section 601
			 of the Clean Air Act (42 U.S.C. 7671).</text>
				</paragraph><paragraph id="H9EC8B44E370943949B92B0BE8A184440"><enum>(4)</enum><text>The term
			 <term>over-the-counter</term> means not subject to section 503(b)(1) of the
			 Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)(1)) or otherwise
			 required pursuant to Federal law to be dispensed only upon issuance of a
			 prescription.</text>
				</paragraph></subsection><subsection id="HD1A62C2071E74D0CBE5A223D1B6322AF"><enum>(d)</enum><header>Sunset</header><text>This
			 section ceases to be effective August 1, 2013.</text>
			</subsection></section></legis-body>
</bill>
